BTSG · Brightspring Health Services Inc
Price
Snapshot
50 fields · last close| Market Cap | $12.40B |
| P/E | 33.87 |
| Float | 163.8M |
| Beta | 1.90 |
| Volatility | 47.5% |
| Exchange | NASDAQ |
| Sector | Health Care |
| Cap tier | Large cap |
| Macro sensitivity | Very High |
| Clavix score | 71.0 |
| Price | 63.22 |
| Change | +0.91% |
| Prev Close | 62.65 |
| Open | 62.82 |
| Day Low | 61.55 |
| Day High | 63.32 |
| Avg Vol | 2 |
| Avg $ Vol | $148.6M |
| 52W High | 73.75 |
| 52W Low | 27.30 |
| 52W Pos | 77.3% |
| From High | −14.28% |
| From Low | +131.58% |
| Max DD 1Y | −23.62% |
| Spread | 0.10% |
| Liquidity | Normal |
| SMA 20 | +6.95% |
| SMA 50 | +5.79% |
| SMA 200 | +18.83% |
| RSI (14) | 59.2 |
| Vol 30D | 36.6% |
| Vol 90D | 50.8% |
| 1Y Range | 27–74 |
| Daily bars | 533 |
| Perf Week | −1.73% |
| Perf Month | +3.90% |
| Perf Quarter | −8.22% |
| Perf Half Y | +36.08% |
| Perf Year | +120.91% |
| Perf YTD | +64.64% |
| Prev Day | +0.91% |
| Clavix | B- |
| Debt / Eq | 1.34 |
| Curr Ratio | 1.57 |
| Int Cover | 2.9× |
| FCF Margin | 3.1% |
| Rev Growth | +28.2% |
| Profit | Profitable |
| Leverage | Moderate |
| Sector rank | 39 / 49 |
Clavix risk grade
regraded every trading dayBTSG grades B-, 71.0 of 100. Steadiest on Sector Resilience (80), most exposed on Price Stability (52, mixed). 2 of the 4 weighted dimensions sit above the Health Care median. Ranks 39 of 49 in Health Care by Clavix score.
How rough the ride is
| BTSG | Health Care median | |
|---|---|---|
| Betavs the overall market · lower is steadier | 1.90 | 0.85 |
| Volatilityannualized | 47.5% | 21.3% |
| Max drawdown, past yearworst peak-to-trough fall | −23.6% | — |
| Typical daily movemedian absolute daily change | 1.48% | — |
| Days beyond ±3%of the last 252 sessions | 55 (22%) | — |
How its days are spread
Daily returns over the last 252 sessions in 1% bins. Moves beyond ±6% land in the end bins.
52-week range
The bar runs from the lowest to the highest close of the last 252 sessions; the marker is the latest close.
Drawdown from the 1-year peak
Percent below the running high over the last 12 months. Zero is a fresh high.
Market sensitivity
| BTSG | Health Care median | |
|---|---|---|
| Beta to the markethow much it swings with the S&P 500 · lower is safer | 1.90 | 0.85 |
| Macro sensitivityrate, dollar and credit exposure bucket | Very High | Moderate 53% of 49 |
Where it sits on the macro scale
Low means rates, the dollar and credit spreads barely move it. Very High means they drive a large share of its swings. The counts are how many Health Care names sit in each bucket.
Where it ranks in its sector
Rank by Clavix score within the sector. Right is the top of the sector.
Price performance
| BTSG | |
|---|---|
| 1 week | −1.7% |
| 1 month | +3.9% |
| Year to date | +64.6% |
| 1 year | +120.9% |
Context for the rank, not itself a risk measure.
Recent coverage, scored
| BTSG | |
|---|---|
| Articles scoredthe most recent scored coverage, up to 30 | 14 since 15 Sep |
| Average score0 most bearish, 100 most bullish | 64 |
| Bullish · bearisharticles above 60 · below 40 | 10 · 0 |
| Directionarticles whose tone is improving vs worsening | 10 ↑ 0 ↓ |
Where the article scores land
Each bar is a 10-point band of article scores. Below 40 reads bearish, above 60 bullish.
Balance sheet, against the sector
The shaded band is the middle half of the 49 Health Care names Clavix covers; the tick is the sector median.
Growth
| BTSG | |
|---|---|
| Revenue growthyear over year | +28.2% |
Financial Health is shown but does not count toward the grade. Why
0–100, higher is safer. The tick on each bar is the Health Care median. Click a dimension for the evidence behind it. Financial Health is shown but does not count toward the grade.
Recent news
most recent scored articles · the chip is the article’s score · click to openI believe BrightSpring Health Services' pharmacy and home-care businesses have a few ways to monetize their sizeable revenues into higher EBITDA over time. BTSG's new oncology distribution wins also grow their addressable market, which is why drug adoption is vital going forward. BTSG's recently acquired home-health branches also have interesting potential as their integration progresses.
Healthcare offers investors a potential combination of offense with forward earnings and defense with rising demand amid persistent macro-economic uncertainty. The healthcare sector is positioned for above-average long-term growth, supported by aging demographics, rising medical demand, and increased spending that's expected to outpace the broader economy. Strong forward revenue, EBITDA, and earnings growth demonstrate how select healthcare services and facilities companies can significantly outperform their sector peers.
Nutex Health (NASDAQ:NUTX - Get Free Report) and BrightSpring Health Services (NASDAQ:BTSG - Get Free Report) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, valuation, analyst recommendations, risk, institutional ownership, profitability and earnings. Risk & Volatility Nutex Health has a […]
Twenty analysts covering BrightSpring Health Services (BTSG) have given the stock an average 'Buy' rating, with eighteen recommending buy and two recommending strong buy. Their average 1-year price target is $70.71.
BrightSpring Health Services (BTSG) shares rose 4.8% in afternoon trading after BMO Capital analyst Sean Dodge reaffirmed an Outperform rating and a $70 price target. The stock was trading at $60.00 at the time.
Nearest peers by size
Health Care| Ticker | Company | Grade | Mkt cap | P/E | Beta | |
|---|---|---|---|---|---|---|
| PEN | Penumbra Inc | A+ | $12.61B | 78.42 | 0.69 | Compare |
| BAX | Baxter International Inc | B | $12.87B | — | 0.67 | Compare |
| DVA | DaVita Inc | B | $11.62B | 13.76 | 0.88 | Compare |
| MOH | Molina Healthcare Inc | B | $10.94B | 23.74 | 0.74 | Compare |
| UHS | Universal Health Services Inc | A- | $10.55B | 6.87 | 1.12 | Compare |
| SOLV | Solventum Corp | B+ | $14.69B | 10.24 | 0.73 | Compare |
| COO | Cooper Companies Inc | B- | $10.38B | 18.55 | 0.83 | Compare |
| GMED | Globus Medical Inc | B | $10.25B | 19.12 | 0.97 | Compare |
You just read one holding. Clavix reads the whole portfolio.
Every position you own, graded on the same five dimensions, with an alert when a grade moves. Three months free on iPhone.